Javier Grau

A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity

NO RECURRENCE OF POSTTRANSPLANTATION KAPOSI???S SARCOMA THREE YEARS AFTER RENAL RETRANSPLANTATION

RENAL TRANSPLANTATION EXPOSES PATIENTS WITH PREVIOUS KAPOSI'S SARCOMA TO A HIGH RISK OF RECURRENCE1

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Skin Cancers after Organ Transplantation

Antipsychotic-Related QTc Prolongation, Torsade de Pointes and Sudden Death

A structure-based computational workflow to predict liability and binding modes of small molecules to hERG

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

Targeting apoptosis in cancer therapy

Cryo-EM Structure of the Open Human Ether-à-go-go -Related K + Channel hERG

Follicular lymphoma international prognostic index

In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes

Antipsychotics and QT prolongation

Akt inhibitors induce apoptosis in chronic lymphocytic leukemia cells

Assessing the proarrhythmic potential of drugs: Current status of models and surrogate parameters of torsades de pointes arrhythmias

Exploring blocker binding to a homology model of the open hERG K⁺ channel using docking and molecular dynamics methods

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

Antipsychotics and the Risk of Sudden Cardiac Death

Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients

Computer Simulations of Structure–Activity Relationships for hERG Channel Blockers

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

Psychotropic Drugs, Cardiac Arrhythmia, and Sudden Death

hERG liability classification models using machine learning techniques

Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems

Multiplex ligation‐dependent probe amplification for detection of genomic alterations in chronic lymphocytic leukaemia

Reinstitution of immunosuppression in a renal transplant recipient after remission of Kaposi's sarcoma.

The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG